 Ross Kedl
Concepts (482)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| CD8-Positive T-Lymphocytes | 60 | 2025 | 847 | 8.610 |
Why?
| | Immunologic Memory | 27 | 2025 | 341 | 5.160 |
Why?
| | Dendritic Cells | 30 | 2022 | 479 | 4.070 |
Why?
| | T-Lymphocytes | 24 | 2024 | 1924 | 2.440 |
Why?
| | Lymphocyte Activation | 27 | 2022 | 1098 | 2.220 |
Why?
| | Vaccines, Subunit | 6 | 2021 | 47 | 2.140 |
Why?
| | Antigen Presentation | 10 | 2017 | 205 | 2.020 |
Why?
| | CD40 Antigens | 12 | 2021 | 88 | 1.800 |
Why?
| | Antigens | 10 | 2017 | 353 | 1.760 |
Why?
| | Mice, Inbred C57BL | 48 | 2025 | 5284 | 1.570 |
Why?
| | Membrane Glycoproteins | 11 | 2014 | 466 | 1.480 |
Why?
| | Interleukin-15 | 6 | 2022 | 82 | 1.470 |
Why?
| | CD27 Ligand | 4 | 2015 | 9 | 1.450 |
Why?
| | Vaccines | 6 | 2019 | 393 | 1.440 |
Why?
| | Adjuvants, Immunologic | 14 | 2018 | 221 | 1.390 |
Why?
| | T-Lymphocyte Subsets | 8 | 2014 | 410 | 1.370 |
Why?
| | Interleukins | 5 | 2021 | 245 | 1.300 |
Why?
| | Mice | 74 | 2025 | 16644 | 1.290 |
Why?
| | Interferon Type I | 7 | 2017 | 140 | 1.270 |
Why?
| | Animals | 94 | 2025 | 34600 | 1.210 |
Why?
| | Interleukin-27 | 4 | 2024 | 12 | 1.200 |
Why?
| | CD4-Positive T-Lymphocytes | 15 | 2021 | 1048 | 1.180 |
Why?
| | Lymph Nodes | 6 | 2017 | 467 | 1.180 |
Why?
| | CD8 Antigens | 4 | 2019 | 76 | 1.110 |
Why?
| | Listeria monocytogenes | 5 | 2023 | 123 | 1.060 |
Why?
| | Mice, Knockout | 25 | 2025 | 2765 | 1.060 |
Why?
| | Mice, Transgenic | 21 | 2021 | 2079 | 1.040 |
Why?
| | Immunity, Innate | 7 | 2022 | 805 | 1.030 |
Why?
| | Ovalbumin | 13 | 2018 | 177 | 0.980 |
Why?
| | Toll-Like Receptor 7 | 10 | 2014 | 37 | 0.980 |
Why?
| | Tumor Necrosis Factor Receptor Superfamily, Member 7 | 3 | 2015 | 28 | 0.960 |
Why?
| | GTP Phosphohydrolases | 1 | 2025 | 84 | 0.930 |
Why?
| | T-Lymphocytes, Helper-Inducer | 3 | 2021 | 137 | 0.920 |
Why?
| | Emergency Responders | 2 | 2021 | 35 | 0.890 |
Why?
| | Cross-Priming | 4 | 2011 | 18 | 0.820 |
Why?
| | Mitochondrial Proteins | 1 | 2025 | 245 | 0.810 |
Why?
| | Cancer Vaccines | 7 | 2016 | 165 | 0.810 |
Why?
| | Melanoma, Experimental | 5 | 2022 | 110 | 0.770 |
Why?
| | Epitopes, T-Lymphocyte | 8 | 2021 | 185 | 0.760 |
Why?
| | Listeriosis | 2 | 2019 | 67 | 0.750 |
Why?
| | Asymptomatic Infections | 1 | 2021 | 24 | 0.730 |
Why?
| | Interleukin-12 | 7 | 2015 | 120 | 0.720 |
Why?
| | Immunity | 2 | 2019 | 132 | 0.720 |
Why?
| | Lymphocyte Depletion | 3 | 2019 | 129 | 0.680 |
Why?
| | Signal Transduction | 15 | 2022 | 4838 | 0.670 |
Why?
| | Adaptive Immunity | 5 | 2020 | 161 | 0.660 |
Why?
| | Poly I-C | 6 | 2015 | 62 | 0.620 |
Why?
| | B-Lymphocytes | 3 | 2023 | 823 | 0.610 |
Why?
| | Immunity, Cellular | 5 | 2015 | 267 | 0.610 |
Why?
| | Antigens, Viral | 2 | 2014 | 174 | 0.610 |
Why?
| | Interferon-gamma | 4 | 2023 | 762 | 0.600 |
Why?
| | Cell Proliferation | 7 | 2025 | 2347 | 0.590 |
Why?
| | Immunotherapy, Adoptive | 2 | 2025 | 297 | 0.590 |
Why?
| | Cell Differentiation | 12 | 2023 | 1901 | 0.570 |
Why?
| | Toll-Like Receptors | 7 | 2020 | 179 | 0.560 |
Why?
| | Adoptive Transfer | 11 | 2020 | 217 | 0.560 |
Why?
| | Receptors, Antigen, T-Cell | 9 | 2020 | 703 | 0.550 |
Why?
| | Aminoquinolines | 4 | 2005 | 21 | 0.550 |
Why?
| | Vaccination | 9 | 2021 | 1349 | 0.550 |
Why?
| | Receptors, Cell Surface | 5 | 2005 | 371 | 0.520 |
Why?
| | Bystander Effect | 1 | 2016 | 16 | 0.520 |
Why?
| | Receptor, Interferon alpha-beta | 3 | 2017 | 33 | 0.510 |
Why?
| | Cell Movement | 8 | 2022 | 939 | 0.500 |
Why?
| | Endothelium, Lymphatic | 1 | 2015 | 12 | 0.500 |
Why?
| | Cytotoxicity, Immunologic | 7 | 2025 | 218 | 0.490 |
Why?
| | Squalene | 1 | 2015 | 7 | 0.480 |
Why?
| | H-2 Antigens | 5 | 2016 | 115 | 0.470 |
Why?
| | Carcinoma, Pancreatic Ductal | 3 | 2023 | 266 | 0.470 |
Why?
| | Breeding | 1 | 2014 | 62 | 0.470 |
Why?
| | Caspase 1 | 1 | 2015 | 142 | 0.450 |
Why?
| | Housing, Animal | 1 | 2014 | 47 | 0.450 |
Why?
| | Bacterial Vaccines | 1 | 2014 | 62 | 0.450 |
Why?
| | OX40 Ligand | 2 | 2011 | 10 | 0.450 |
Why?
| | Antigens, Neoplasm | 5 | 2018 | 310 | 0.440 |
Why?
| | Caspases | 1 | 2015 | 242 | 0.440 |
Why?
| | Viral Vaccines | 2 | 2014 | 94 | 0.430 |
Why?
| | Immunization | 9 | 2020 | 412 | 0.430 |
Why?
| | Interleukin-18 | 1 | 2015 | 237 | 0.430 |
Why?
| | Cytokines | 13 | 2019 | 1987 | 0.420 |
Why?
| | Cell Lineage | 3 | 2013 | 334 | 0.420 |
Why?
| | Toll-Like Receptor 4 | 1 | 2015 | 263 | 0.410 |
Why?
| | Endothelial Cells | 1 | 2017 | 701 | 0.400 |
Why?
| | Receptors, OX40 | 1 | 2011 | 15 | 0.390 |
Why?
| | Tumor Necrosis Factors | 1 | 2011 | 10 | 0.390 |
Why?
| | Up-Regulation | 5 | 2022 | 828 | 0.380 |
Why?
| | Spike Glycoprotein, Coronavirus | 3 | 2022 | 108 | 0.380 |
Why?
| | T-Cell Antigen Receptor Specificity | 4 | 2016 | 51 | 0.380 |
Why?
| | Spleen | 8 | 2019 | 513 | 0.380 |
Why?
| | Antibodies, Viral | 6 | 2023 | 603 | 0.380 |
Why?
| | Virus Diseases | 1 | 2014 | 209 | 0.380 |
Why?
| | Chemokines | 4 | 2020 | 222 | 0.380 |
Why?
| | Immunity, Humoral | 3 | 2023 | 117 | 0.380 |
Why?
| | Vaccinia | 3 | 2018 | 22 | 0.380 |
Why?
| | Cells, Cultured | 11 | 2019 | 4010 | 0.370 |
Why?
| | Orthomyxoviridae Infections | 3 | 2021 | 68 | 0.370 |
Why?
| | Vaccines, Conjugate | 2 | 2010 | 63 | 0.360 |
Why?
| | Antigen-Presenting Cells | 5 | 2018 | 150 | 0.350 |
Why?
| | Pancreatic Neoplasms | 3 | 2023 | 878 | 0.340 |
Why?
| | Female | 36 | 2022 | 68510 | 0.320 |
Why?
| | Humans | 42 | 2025 | 129116 | 0.320 |
Why?
| | Th1 Cells | 5 | 2019 | 136 | 0.310 |
Why?
| | Industry | 1 | 2009 | 63 | 0.300 |
Why?
| | Career Mobility | 1 | 2009 | 69 | 0.300 |
Why?
| | Lymphocyte Count | 4 | 2021 | 151 | 0.290 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 3 | 2017 | 40 | 0.290 |
Why?
| | Myeloid Cells | 4 | 2021 | 142 | 0.270 |
Why?
| | Career Choice | 1 | 2009 | 211 | 0.270 |
Why?
| | Interleukin-2 Receptor beta Subunit | 2 | 2019 | 18 | 0.260 |
Why?
| | Skin Neoplasms | 2 | 2022 | 833 | 0.260 |
Why?
| | Radiation Chimera | 3 | 2014 | 29 | 0.260 |
Why?
| | Universities | 1 | 2009 | 402 | 0.260 |
Why?
| | Intramolecular Oxidoreductases | 1 | 2006 | 62 | 0.260 |
Why?
| | Viral Proteins | 2 | 2001 | 321 | 0.260 |
Why?
| | Toxoplasmosis | 2 | 2024 | 37 | 0.260 |
Why?
| | Toxoplasma | 2 | 2024 | 39 | 0.260 |
Why?
| | Oligopeptides | 2 | 2012 | 258 | 0.250 |
Why?
| | Binding, Competitive | 2 | 2003 | 199 | 0.250 |
Why?
| | Neoplasm Transplantation | 3 | 2006 | 258 | 0.240 |
Why?
| | CD11b Antigen | 2 | 2014 | 59 | 0.240 |
Why?
| | Mitochondrial Membrane Transport Proteins | 1 | 2025 | 42 | 0.240 |
Why?
| | Mice, 129 Strain | 2 | 2017 | 80 | 0.240 |
Why?
| | Mitochondrial Dynamics | 1 | 2025 | 37 | 0.240 |
Why?
| | CD11c Antigen | 2 | 2008 | 41 | 0.230 |
Why?
| | Repressor Proteins | 3 | 2017 | 400 | 0.230 |
Why?
| | Mice, Inbred BALB C | 10 | 2020 | 1230 | 0.230 |
Why?
| | Seroepidemiologic Studies | 2 | 2021 | 156 | 0.220 |
Why?
| | B7-H1 Antigen | 4 | 2021 | 189 | 0.220 |
Why?
| | Monocytes | 4 | 2024 | 543 | 0.220 |
Why?
| | Influenza A virus | 2 | 2021 | 102 | 0.210 |
Why?
| | Immunophenotyping | 3 | 2019 | 312 | 0.210 |
Why?
| | Peptide Fragments | 4 | 2016 | 686 | 0.210 |
Why?
| | Cell Adhesion Molecules | 2 | 2022 | 172 | 0.200 |
Why?
| | Omentum | 1 | 2022 | 11 | 0.200 |
Why?
| | Chemokine CXCL10 | 2 | 2022 | 34 | 0.200 |
Why?
| | Egg Proteins | 2 | 2001 | 17 | 0.200 |
Why?
| | Transforming Growth Factor beta | 2 | 2019 | 449 | 0.200 |
Why?
| | Graft Rejection | 2 | 2017 | 558 | 0.200 |
Why?
| | Sentinel Lymph Node | 1 | 2022 | 42 | 0.200 |
Why?
| | Lung | 6 | 2021 | 3752 | 0.200 |
Why?
| | Imidazoles | 5 | 2014 | 229 | 0.200 |
Why?
| | Receptors, CXCR3 | 1 | 2022 | 16 | 0.190 |
Why?
| | Transcription Factors | 4 | 2023 | 1632 | 0.190 |
Why?
| | Chemokine CXCL9 | 1 | 2022 | 25 | 0.190 |
Why?
| | Gene Rearrangement, T-Lymphocyte | 1 | 2001 | 15 | 0.190 |
Why?
| | Gene Expression | 3 | 2016 | 1462 | 0.190 |
Why?
| | Immunotherapy | 5 | 2023 | 588 | 0.190 |
Why?
| | Microspheres | 2 | 2021 | 124 | 0.190 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2022 | 1353 | 0.190 |
Why?
| | Portraits as Topic | 1 | 2021 | 2 | 0.190 |
Why?
| | Microfilament Proteins | 1 | 2022 | 125 | 0.190 |
Why?
| | Receptors, CCR2 | 1 | 2021 | 37 | 0.180 |
Why?
| | Immunologic Factors | 1 | 2003 | 229 | 0.180 |
Why?
| | Receptors, Virus | 1 | 2021 | 83 | 0.180 |
Why?
| | Immunoglobulin M | 2 | 2022 | 272 | 0.180 |
Why?
| | Male | 20 | 2021 | 63194 | 0.180 |
Why?
| | Immunoassay | 1 | 2021 | 103 | 0.180 |
Why?
| | Luminescent Proteins | 1 | 2001 | 176 | 0.180 |
Why?
| | Specimen Handling | 1 | 2022 | 165 | 0.180 |
Why?
| | Transcriptional Activation | 2 | 2022 | 356 | 0.170 |
Why?
| | Immunity, Mucosal | 1 | 2021 | 94 | 0.170 |
Why?
| | Cell Communication | 4 | 2013 | 299 | 0.170 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2005 | 1192 | 0.170 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2022 | 206 | 0.170 |
Why?
| | Fluorescent Dyes | 1 | 2001 | 313 | 0.170 |
Why?
| | Actins | 1 | 2022 | 402 | 0.170 |
Why?
| | Phosphoproteins | 1 | 2022 | 330 | 0.170 |
Why?
| | Primary Cell Culture | 2 | 2021 | 159 | 0.170 |
Why?
| | Macrophages | 2 | 2021 | 1466 | 0.170 |
Why?
| | Integrin alpha Chains | 3 | 2019 | 22 | 0.160 |
Why?
| | Glycoproteins | 1 | 2001 | 337 | 0.160 |
Why?
| | Influenza Vaccines | 2 | 2021 | 536 | 0.160 |
Why?
| | Disease Models, Animal | 5 | 2021 | 3953 | 0.160 |
Why?
| | Joints | 1 | 2020 | 95 | 0.160 |
Why?
| | Disease Resistance | 1 | 2019 | 31 | 0.160 |
Why?
| | Allergens | 2 | 2021 | 383 | 0.160 |
Why?
| | Homeostasis | 2 | 2016 | 605 | 0.160 |
Why?
| | Costimulatory and Inhibitory T-Cell Receptors | 1 | 2019 | 7 | 0.160 |
Why?
| | Chikungunya Fever | 1 | 2020 | 76 | 0.160 |
Why?
| | Antibodies, Monoclonal | 4 | 2019 | 1359 | 0.160 |
Why?
| | Mitochondria | 1 | 2025 | 854 | 0.160 |
Why?
| | Chikungunya virus | 1 | 2020 | 76 | 0.150 |
Why?
| | Aerobiosis | 1 | 2018 | 23 | 0.150 |
Why?
| | Antineoplastic Agents, Immunological | 1 | 2021 | 174 | 0.150 |
Why?
| | T-Box Domain Proteins | 1 | 2019 | 96 | 0.150 |
Why?
| | Flow Cytometry | 5 | 2016 | 1142 | 0.150 |
Why?
| | Peptides | 5 | 2013 | 911 | 0.150 |
Why?
| | Immune Tolerance | 3 | 2012 | 349 | 0.150 |
Why?
| | Multiple Sclerosis | 1 | 2024 | 437 | 0.150 |
Why?
| | Hypersensitivity | 1 | 2021 | 250 | 0.150 |
Why?
| | Gene Expression Regulation | 6 | 2013 | 2508 | 0.150 |
Why?
| | Vaccines, DNA | 2 | 2009 | 28 | 0.150 |
Why?
| | Cell Membrane | 1 | 2001 | 722 | 0.150 |
Why?
| | Vaccinia virus | 3 | 2010 | 43 | 0.140 |
Why?
| | Lymphocytes | 2 | 2022 | 369 | 0.140 |
Why?
| | Antigens, CD | 4 | 2019 | 483 | 0.140 |
Why?
| | Head and Neck Neoplasms | 1 | 2022 | 534 | 0.140 |
Why?
| | Interleukin-10 | 1 | 2019 | 299 | 0.140 |
Why?
| | Killer Cells, Natural | 2 | 2019 | 426 | 0.140 |
Why?
| | Gene Products, gag | 3 | 2006 | 36 | 0.140 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2018 | 168 | 0.140 |
Why?
| | Friend murine leukemia virus | 1 | 2017 | 29 | 0.140 |
Why?
| | Transplantation Tolerance | 1 | 2017 | 34 | 0.140 |
Why?
| | Cytidine Deaminase | 1 | 2017 | 58 | 0.130 |
Why?
| | Glycolysis | 1 | 2018 | 293 | 0.130 |
Why?
| | Islets of Langerhans Transplantation | 1 | 2017 | 60 | 0.130 |
Why?
| | Antibodies | 3 | 2015 | 391 | 0.130 |
Why?
| | Melanoma | 2 | 2022 | 752 | 0.130 |
Why?
| | Epitopes | 3 | 2007 | 466 | 0.120 |
Why?
| | Myeloid Differentiation Factor 88 | 3 | 2011 | 95 | 0.120 |
Why?
| | Triple Negative Breast Neoplasms | 1 | 2018 | 191 | 0.120 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 2 | 2016 | 334 | 0.120 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2016 | 162 | 0.120 |
Why?
| | AIDS Vaccines | 2 | 2005 | 47 | 0.120 |
Why?
| | Caspases, Initiator | 1 | 2015 | 18 | 0.120 |
Why?
| | DNA-Binding Proteins | 2 | 2018 | 1423 | 0.120 |
Why?
| | Minor Histocompatibility Antigens | 1 | 2015 | 46 | 0.120 |
Why?
| | Antibody Formation | 2 | 2013 | 288 | 0.120 |
Why?
| | Toll-Like Receptor 9 | 2 | 2006 | 31 | 0.120 |
Why?
| | Adenocarcinoma | 1 | 2022 | 889 | 0.120 |
Why?
| | Neoplasm Proteins | 1 | 2018 | 421 | 0.120 |
Why?
| | Immunoglobulin G | 5 | 2022 | 846 | 0.120 |
Why?
| | Host-Pathogen Interactions | 1 | 2018 | 348 | 0.120 |
Why?
| | Reoviridae | 1 | 1995 | 37 | 0.120 |
Why?
| | Smallpox Vaccine | 1 | 2014 | 22 | 0.120 |
Why?
| | Coculture Techniques | 1 | 2015 | 225 | 0.120 |
Why?
| | Receptors, Cytokine | 1 | 2014 | 35 | 0.120 |
Why?
| | Antibodies, Neutralizing | 1 | 2017 | 264 | 0.120 |
Why?
| | STAT Transcription Factors | 1 | 2014 | 14 | 0.120 |
Why?
| | Skin Transplantation | 1 | 2015 | 88 | 0.120 |
Why?
| | Receptors, Interleukin | 1 | 2014 | 42 | 0.120 |
Why?
| | Pandemics | 1 | 2023 | 1491 | 0.120 |
Why?
| | Interleukin-2 | 5 | 2023 | 431 | 0.110 |
Why?
| | Dose-Response Relationship, Immunologic | 1 | 2014 | 81 | 0.110 |
Why?
| | Liposomes | 4 | 2011 | 168 | 0.110 |
Why?
| | Virus Replication | 1 | 2017 | 444 | 0.110 |
Why?
| | Tumor Cells, Cultured | 3 | 2021 | 930 | 0.110 |
Why?
| | Colorado | 2 | 2021 | 4394 | 0.110 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1995 | 368 | 0.110 |
Why?
| | Capsid Proteins | 1 | 1995 | 91 | 0.110 |
Why?
| | Leukocytes, Mononuclear | 3 | 2013 | 538 | 0.110 |
Why?
| | Gangliosides | 1 | 2013 | 19 | 0.110 |
Why?
| | Growth Hormone | 1 | 2013 | 96 | 0.110 |
Why?
| | Proto-Oncogene Proteins pp60(c-src) | 1 | 2013 | 12 | 0.110 |
Why?
| | Autoantigens | 1 | 2016 | 416 | 0.100 |
Why?
| | Positive Regulatory Domain I-Binding Factor 1 | 1 | 2013 | 18 | 0.100 |
Why?
| | Autoimmunity | 2 | 2019 | 860 | 0.100 |
Why?
| | Genes, MHC Class II | 1 | 2013 | 72 | 0.100 |
Why?
| | Transplantation Chimera | 1 | 2013 | 54 | 0.100 |
Why?
| | Phenotype | 2 | 2019 | 3058 | 0.100 |
Why?
| | Clone Cells | 4 | 2001 | 255 | 0.100 |
Why?
| | Whole-Body Irradiation | 1 | 2013 | 75 | 0.100 |
Why?
| | Guidelines as Topic | 1 | 2014 | 261 | 0.100 |
Why?
| | Muramidase | 1 | 2012 | 75 | 0.100 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 1 | 2012 | 100 | 0.100 |
Why?
| | Histocompatibility Antigens Class II | 2 | 2007 | 360 | 0.100 |
Why?
| | Recombinant Proteins | 2 | 2013 | 1284 | 0.100 |
Why?
| | Antigenic Variation | 1 | 2011 | 9 | 0.100 |
Why?
| | Moloney murine leukemia virus | 1 | 2011 | 12 | 0.100 |
Why?
| | Receptors, Interleukin-12 | 1 | 2011 | 7 | 0.090 |
Why?
| | Thymus Gland | 1 | 2013 | 309 | 0.090 |
Why?
| | Toll-Like Receptor 3 | 2 | 2014 | 27 | 0.090 |
Why?
| | Cell Line, Tumor | 4 | 2025 | 3184 | 0.090 |
Why?
| | Myocarditis | 1 | 2012 | 98 | 0.090 |
Why?
| | RNA-Binding Proteins | 1 | 1995 | 388 | 0.090 |
Why?
| | Immunoglobulin E | 1 | 2012 | 329 | 0.090 |
Why?
| | Transplantation, Homologous | 3 | 2017 | 396 | 0.090 |
Why?
| | Viral Envelope Proteins | 1 | 2011 | 81 | 0.090 |
Why?
| | Nasal Mucosa | 1 | 2011 | 107 | 0.090 |
Why?
| | Nucleic Acids | 1 | 2011 | 60 | 0.090 |
Why?
| | Time Factors | 1 | 2021 | 6518 | 0.090 |
Why?
| | Hyaluronan Receptors | 2 | 2009 | 97 | 0.090 |
Why?
| | Body Weight | 1 | 2014 | 932 | 0.090 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2015 | 818 | 0.090 |
Why?
| | Macaca mulatta | 3 | 2019 | 148 | 0.080 |
Why?
| | Breast Neoplasms | 1 | 2022 | 2150 | 0.080 |
Why?
| | Toll-Like Receptor 5 | 1 | 2009 | 14 | 0.080 |
Why?
| | Granzymes | 2 | 2022 | 46 | 0.080 |
Why?
| | Polyethyleneimine | 1 | 2009 | 18 | 0.080 |
Why?
| | Organ Specificity | 2 | 2001 | 291 | 0.080 |
Why?
| | Liver | 2 | 2016 | 1833 | 0.080 |
Why?
| | Toll-Like Receptor 8 | 2 | 2006 | 5 | 0.080 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 2 | 2022 | 209 | 0.080 |
Why?
| | Amino Acid Sequence | 3 | 2016 | 2041 | 0.080 |
Why?
| | Injections, Intravenous | 2 | 2013 | 193 | 0.080 |
Why?
| | Anti-Inflammatory Agents | 1 | 2012 | 471 | 0.080 |
Why?
| | Bronchial Hyperreactivity | 1 | 2009 | 104 | 0.080 |
Why?
| | Autoimmune Diseases | 1 | 2012 | 425 | 0.080 |
Why?
| | Kupffer Cells | 1 | 2008 | 49 | 0.080 |
Why?
| | Lectins, C-Type | 2 | 2020 | 64 | 0.080 |
Why?
| | Proto-Oncogene Proteins | 2 | 2002 | 634 | 0.070 |
Why?
| | Transcription, Genetic | 1 | 2014 | 1403 | 0.070 |
Why?
| | Mutation | 1 | 2019 | 3700 | 0.070 |
Why?
| | Protein Binding | 2 | 2022 | 2106 | 0.070 |
Why?
| | Baculoviridae | 1 | 2008 | 44 | 0.070 |
Why?
| | Interleukin-6 | 1 | 2012 | 718 | 0.070 |
Why?
| | Insecta | 1 | 2008 | 64 | 0.070 |
Why?
| | Saccharomyces cerevisiae | 1 | 2012 | 525 | 0.070 |
Why?
| | B7-1 Antigen | 3 | 2009 | 58 | 0.070 |
Why?
| | Interferon Inducers | 2 | 2008 | 7 | 0.070 |
Why?
| | Tumor Microenvironment | 2 | 2022 | 622 | 0.070 |
Why?
| | Research Personnel | 1 | 2009 | 160 | 0.070 |
Why?
| | Major Histocompatibility Complex | 2 | 2008 | 229 | 0.070 |
Why?
| | RNA, Small Interfering | 1 | 2009 | 571 | 0.070 |
Why?
| | Immunosuppressive Agents | 2 | 2009 | 690 | 0.070 |
Why?
| | Histocompatibility Antigen H-2D | 2 | 2008 | 21 | 0.070 |
Why?
| | Injections, Intradermal | 1 | 2006 | 13 | 0.070 |
Why?
| | Oleic Acids | 1 | 2006 | 10 | 0.070 |
Why?
| | Injections, Intraperitoneal | 2 | 2013 | 106 | 0.060 |
Why?
| | Mannitol | 1 | 2006 | 35 | 0.060 |
Why?
| | Inflammation Mediators | 1 | 2009 | 500 | 0.060 |
Why?
| | T-Lymphocytes, Cytotoxic | 2 | 2022 | 168 | 0.060 |
Why?
| | HIV Antigens | 1 | 2005 | 17 | 0.060 |
Why?
| | Lung Neoplasms | 1 | 2018 | 2329 | 0.060 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2013 | 953 | 0.060 |
Why?
| | Neoplasms, Experimental | 1 | 2006 | 169 | 0.060 |
Why?
| | Oligodeoxyribonucleotides | 4 | 2006 | 138 | 0.060 |
Why?
| | Nanoparticles | 1 | 2009 | 368 | 0.060 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 1 | 2025 | 39 | 0.060 |
Why?
| | Cell Adhesion | 1 | 2006 | 445 | 0.060 |
Why?
| | CD40 Ligand | 2 | 2018 | 38 | 0.060 |
Why?
| | Genes, Reporter | 2 | 2002 | 266 | 0.060 |
Why?
| | Cytotoxicity Tests, Immunologic | 1 | 2004 | 42 | 0.060 |
Why?
| | Transfection | 3 | 2019 | 896 | 0.060 |
Why?
| | Acute Kidney Injury | 1 | 2012 | 774 | 0.060 |
Why?
| | Ovarian Neoplasms | 1 | 2009 | 490 | 0.050 |
Why?
| | Neoplasms | 2 | 2009 | 2475 | 0.050 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2023 | 76 | 0.050 |
Why?
| | Genes, bcl-2 | 1 | 2002 | 20 | 0.050 |
Why?
| | Leukemia | 1 | 2025 | 229 | 0.050 |
Why?
| | Apoptosis | 1 | 2011 | 2438 | 0.050 |
Why?
| | Ubiquitin C | 1 | 2001 | 3 | 0.050 |
Why?
| | Interphase | 2 | 1999 | 31 | 0.050 |
Why?
| | Pregnancy | 1 | 2014 | 6375 | 0.050 |
Why?
| | Asthma | 2 | 2012 | 2219 | 0.050 |
Why?
| | CTLA-4 Antigen | 2 | 2019 | 89 | 0.050 |
Why?
| | THP-1 Cells | 1 | 2021 | 24 | 0.050 |
Why?
| | Cytoskeletal Proteins | 1 | 2022 | 142 | 0.050 |
Why?
| | T-Lymphocytes, Regulatory | 2 | 2022 | 376 | 0.050 |
Why?
| | Polymerization | 1 | 2022 | 124 | 0.050 |
Why?
| | Lymph Node Excision | 1 | 2022 | 165 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2002 | 235 | 0.050 |
Why?
| | Transcriptome | 2 | 2019 | 883 | 0.050 |
Why?
| | Chemotaxis, Leukocyte | 1 | 2001 | 136 | 0.050 |
Why?
| | World Health Organization | 1 | 2022 | 110 | 0.050 |
Why?
| | Macromolecular Substances | 1 | 2001 | 211 | 0.050 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2001 | 757 | 0.050 |
Why?
| | Cell Line | 2 | 2005 | 2737 | 0.050 |
Why?
| | Middle Aged | 3 | 2021 | 31074 | 0.050 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2023 | 227 | 0.050 |
Why?
| | RNA, Messenger | 3 | 2024 | 2676 | 0.040 |
Why?
| | Tumor Burden | 1 | 2022 | 283 | 0.040 |
Why?
| | Intraepithelial Lymphocytes | 1 | 2020 | 14 | 0.040 |
Why?
| | Drosophila Proteins | 1 | 2002 | 187 | 0.040 |
Why?
| | Receptors, Mitogen | 1 | 2020 | 9 | 0.040 |
Why?
| | Acrylic Resins | 1 | 2020 | 45 | 0.040 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2021 | 195 | 0.040 |
Why?
| | RNA, Viral | 1 | 2024 | 617 | 0.040 |
Why?
| | STAT3 Transcription Factor | 1 | 2022 | 190 | 0.040 |
Why?
| | Green Fluorescent Proteins | 1 | 2001 | 382 | 0.040 |
Why?
| | Keratinocytes | 1 | 2021 | 243 | 0.040 |
Why?
| | Mice, Inbred Strains | 1 | 2000 | 402 | 0.040 |
Why?
| | Lipopolysaccharides | 4 | 2006 | 856 | 0.040 |
Why?
| | Gene Expression Profiling | 3 | 2002 | 1689 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2021 | 335 | 0.040 |
Why?
| | Combined Modality Therapy | 1 | 2022 | 1209 | 0.040 |
Why?
| | Aged | 2 | 2016 | 22083 | 0.040 |
Why?
| | Cell Compartmentation | 1 | 2019 | 51 | 0.040 |
Why?
| | Clonal Anergy | 1 | 1999 | 51 | 0.040 |
Why?
| | HIV-1 | 1 | 2005 | 842 | 0.040 |
Why?
| | Arthritis | 1 | 2020 | 114 | 0.040 |
Why?
| | Recombinant Fusion Proteins | 1 | 2001 | 634 | 0.040 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 1999 | 133 | 0.040 |
Why?
| | Homozygote | 1 | 2019 | 193 | 0.040 |
Why?
| | Survival Analysis | 1 | 2022 | 1265 | 0.040 |
Why?
| | Siblings | 1 | 2019 | 215 | 0.040 |
Why?
| | Immunoconjugates | 1 | 1999 | 102 | 0.040 |
Why?
| | Plasmids | 2 | 2011 | 357 | 0.040 |
Why?
| | Cations | 2 | 2009 | 79 | 0.040 |
Why?
| | Genome | 1 | 2000 | 277 | 0.040 |
Why?
| | Adult | 2 | 2021 | 35510 | 0.040 |
Why?
| | Receptors, Immunologic | 1 | 2019 | 209 | 0.040 |
Why?
| | Acute Disease | 1 | 2020 | 968 | 0.040 |
Why?
| | Cytomegalovirus Infections | 1 | 2019 | 187 | 0.030 |
Why?
| | Promoter Regions, Genetic | 1 | 2001 | 1200 | 0.030 |
Why?
| | Arenaviridae Infections | 1 | 2016 | 7 | 0.030 |
Why?
| | Biomarkers | 2 | 2021 | 3896 | 0.030 |
Why?
| | Cell Degranulation | 1 | 2016 | 42 | 0.030 |
Why?
| | Lymphocytic choriomeningitis virus | 1 | 2016 | 22 | 0.030 |
Why?
| | Skin | 1 | 2021 | 719 | 0.030 |
Why?
| | Cell Separation | 2 | 2012 | 313 | 0.030 |
Why?
| | Carboxymethylcellulose Sodium | 1 | 2015 | 3 | 0.030 |
Why?
| | Polylysine | 1 | 2015 | 17 | 0.030 |
Why?
| | CpG Islands | 2 | 2006 | 152 | 0.030 |
Why?
| | Histocompatibility Testing | 1 | 2015 | 120 | 0.030 |
Why?
| | Cellular Senescence | 1 | 2016 | 174 | 0.030 |
Why?
| | Molecular Sequence Data | 2 | 2001 | 2819 | 0.030 |
Why?
| | Chronic Disease | 1 | 2020 | 1706 | 0.030 |
Why?
| | Disease Progression | 1 | 2022 | 2613 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2020 | 706 | 0.030 |
Why?
| | Down-Regulation | 2 | 2011 | 634 | 0.030 |
Why?
| | Hypodermoclysis | 1 | 2013 | 4 | 0.030 |
Why?
| | Models, Molecular | 1 | 2019 | 1483 | 0.030 |
Why?
| | Stem Cells | 1 | 1998 | 579 | 0.030 |
Why?
| | Chemistry, Pharmaceutical | 1 | 2013 | 100 | 0.030 |
Why?
| | Species Specificity | 1 | 1995 | 570 | 0.030 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 1021 | 0.030 |
Why?
| | Immunological Synapses | 1 | 2012 | 16 | 0.030 |
Why?
| | Rats, Inbred Lew | 1 | 2012 | 92 | 0.030 |
Why?
| | Interleukin-1 | 2 | 2012 | 961 | 0.030 |
Why?
| | Respiratory Mucosa | 1 | 2015 | 306 | 0.030 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2015 | 627 | 0.020 |
Why?
| | Inflammation | 2 | 2020 | 2668 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 326 | 0.020 |
Why?
| | Interferon-alpha | 2 | 2005 | 192 | 0.020 |
Why?
| | Particle Size | 1 | 2013 | 352 | 0.020 |
Why?
| | Clodronic Acid | 1 | 2012 | 12 | 0.020 |
Why?
| | Cattle | 1 | 1995 | 962 | 0.020 |
Why?
| | Chemokine CXCL1 | 1 | 2012 | 73 | 0.020 |
Why?
| | Aerosols | 1 | 2012 | 172 | 0.020 |
Why?
| | Diphtheria Toxin | 1 | 2012 | 61 | 0.020 |
Why?
| | Melioidosis | 1 | 2011 | 5 | 0.020 |
Why?
| | Chemokine CCL2 | 1 | 2012 | 118 | 0.020 |
Why?
| | Burkholderia pseudomallei | 1 | 2011 | 10 | 0.020 |
Why?
| | Bone Marrow | 1 | 2013 | 268 | 0.020 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2012 | 147 | 0.020 |
Why?
| | Administration, Intranasal | 1 | 2011 | 82 | 0.020 |
Why?
| | Th17 Cells | 1 | 2012 | 82 | 0.020 |
Why?
| | Models, Animal | 1 | 2013 | 367 | 0.020 |
Why?
| | Administration, Inhalation | 1 | 2012 | 664 | 0.020 |
Why?
| | Phylogeny | 1 | 1995 | 846 | 0.020 |
Why?
| | Lipoproteins | 1 | 2012 | 171 | 0.020 |
Why?
| | Pulmonary Emphysema | 1 | 2013 | 244 | 0.020 |
Why?
| | Cysteine | 1 | 2012 | 188 | 0.020 |
Why?
| | Weight Gain | 1 | 2013 | 505 | 0.020 |
Why?
| | Interleukin-1beta | 1 | 2012 | 374 | 0.020 |
Why?
| | Methacholine Chloride | 1 | 2009 | 51 | 0.020 |
Why?
| | Echocardiography | 1 | 2012 | 627 | 0.020 |
Why?
| | Prostaglandin D2 | 1 | 2008 | 20 | 0.020 |
Why?
| | Ischemia | 1 | 2012 | 395 | 0.020 |
Why?
| | Cell Death | 2 | 2001 | 348 | 0.020 |
Why?
| | Heart | 1 | 2012 | 639 | 0.020 |
Why?
| | CD4 Antigens | 1 | 2009 | 138 | 0.020 |
Why?
| | Metabolomics | 1 | 2013 | 599 | 0.020 |
Why?
| | Cell Transplantation | 1 | 2008 | 35 | 0.020 |
Why?
| | Dinoprostone | 1 | 2008 | 187 | 0.020 |
Why?
| | Cell Survival | 2 | 2002 | 1077 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2007 | 292 | 0.020 |
Why?
| | Risk Factors | 1 | 2021 | 9767 | 0.020 |
Why?
| | Zymosan | 1 | 2006 | 65 | 0.020 |
Why?
| | Nucleocapsid Proteins | 1 | 2005 | 25 | 0.020 |
Why?
| | Age Factors | 1 | 2013 | 3120 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2008 | 616 | 0.020 |
Why?
| | Primates | 1 | 2005 | 118 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2019 | 10226 | 0.010 |
Why?
| | Rats | 1 | 2012 | 5173 | 0.010 |
Why?
| | Ligands | 1 | 2005 | 614 | 0.010 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2006 | 391 | 0.010 |
Why?
| | Nitric Oxide | 1 | 2008 | 886 | 0.010 |
Why?
| | bcl-X Protein | 1 | 2002 | 41 | 0.010 |
Why?
| | Superantigens | 1 | 2002 | 70 | 0.010 |
Why?
| | Mycobacterium tuberculosis | 1 | 2006 | 314 | 0.010 |
Why?
| | Interleukin-3 | 1 | 2002 | 24 | 0.010 |
Why?
| | Receptors, CCR7 | 1 | 2002 | 27 | 0.010 |
Why?
| | Models, Immunological | 1 | 2002 | 94 | 0.010 |
Why?
| | Receptors, Chemokine | 1 | 2002 | 45 | 0.010 |
Why?
| | Chemokines, CXC | 1 | 2002 | 68 | 0.010 |
Why?
| | Genetic Variation | 1 | 2007 | 934 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2013 | 7064 | 0.010 |
Why?
| | Aging | 1 | 2011 | 1771 | 0.010 |
Why?
| | Cell Division | 1 | 2002 | 779 | 0.010 |
Why?
| | Phorbol Esters | 1 | 2000 | 14 | 0.010 |
Why?
| | Expressed Sequence Tags | 1 | 2000 | 41 | 0.010 |
Why?
| | Jurkat Cells | 1 | 2000 | 131 | 0.010 |
Why?
| | Abatacept | 1 | 1999 | 47 | 0.010 |
Why?
| | Nucleic Acid Hybridization | 1 | 1999 | 188 | 0.010 |
Why?
| | Antigens, Differentiation | 1 | 1999 | 82 | 0.010 |
Why?
| | Hybridomas | 1 | 1999 | 234 | 0.010 |
Why?
| | Immunization, Secondary | 1 | 1999 | 87 | 0.010 |
Why?
| | Antioxidants | 1 | 2002 | 543 | 0.010 |
Why?
| | NF-kappa B | 1 | 2002 | 652 | 0.010 |
Why?
| | Hot Temperature | 1 | 2000 | 364 | 0.010 |
Why?
| | Databases, Factual | 1 | 2000 | 1279 | 0.010 |
Why?
|
|
Kedl's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|